321 HARRISON AVENUE, BOSTON, MA
Market cap: $1.3B (2/09/2026)
Price: $19.57
SVP Edmund Dunn Retirement; Matthew Bowen Named Successor
Announces Pricing of $300 Million Underwritten Public Offering
Monte Rosa Therapeutics Terminates ATM Prospectus Effective January 7, 2026
Investor Presentation
Announces Third Quarter 2025 Financial Results and Business Updates
Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
Announces Second Quarter 2025 Financial Results and Business Updates
Shareholder votes
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Notice of Proposed Sale of Securities